Table 4.
Baseline | 0.3 μM Tertiapin-Q wash-in | 0.3 μM Tertiapin-Q 50 μM Ba2+ wash-in | |
---|---|---|---|
Dorsal CA1 | |||
Vm, mV | −68.0 ± 0.6 (n = 7) | −63.3 ± 0.7 (n = 7)* | −61.2 ± 1.1 (n = 7)* |
Rin, MΩ | 62.4 ± 1.5 (n = 7) | 80.5 ± 3.6 (n = 7)* | 92.7 ± 4.7 (n = 7)* |
Ventral CA1 | |||
Vm, mV | −64.6 ± 0.5 (n = 5) | −62.9 ± 0.6 (n = 5) | −61.4 ± 0.6 (n = 5)* |
Rin, MΩ | 86.9 ± 3.0 (n = 5) | 95.0 ± 3.4 (n = 5) | 102 ± 1.9 (n = 5)* |
Statistically significant (
P < 0.0167, 1-way ANOVA with Bonferroni post hoc test compared with baseline).